Longer peptide sequences are likely to contain both HLA class I and class II peptides and would, therefore, activate tumor-directed CD8+ and CD4+ T-cells facilitated by cross presentation of antigens in antigen-presenting cells (i.e. DC, macrophages, B-cells as well as tumor cells) (58, 73). The gene discussed is CD4; the disease is neoplasm.